A supplier suspends shipping to Canada after 9 consecutive customs detentions
The route did not close because of a rule about peptides.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Stability
Lyophilisation does not stop degradation. It slows every pathway by removing the solvent that most of them require, and the residue of solvent that remains sets the rate.
The most informative number about the long-term prospects of a lyophilised vial is one that almost nobody in this trade reports: residual moisture, determined by Karl Fischer titration or by loss on drying, expressed as a percentage of cake mass. Regulated products carry a specification for it, usually in the low single figures, because the relationship between residual water and the rate of deamidation and hydrolysis in the solid state is steep. A cake at four per cent water and a cake at one per cent water are the same product with materially different futures, and no purity certificate distinguishes them.
Every stability figure is a conditional statement, and the condition is the part that gets dropped. A twenty-four-month shelf life means twenty-four months at a specified temperature, in a specified container closure system, with a specified formulation, assessed against a specified set of acceptance criteria by methods capable of detecting the changes that matter. Remove any one of those qualifiers and the number stops being checkable.
The trade routinely reports the number and none of the qualifiers. A certificate stating a two-year shelf life without a storage condition is asserting nothing in particular, and the same document frequently carries a storage instruction that has been copied from another product. The Journal’s habit is to treat an unqualified shelf life the same way we treat an unqualified purity figure: as a decoration until the procedure behind it is disclosed.
There is also a vocabulary problem worth clearing up. An expiry date states that material should not be used beyond it. A retest date states that material should be re-examined against specification before use beyond it, and is the appropriate concept for a stable chemical entity held in a controlled environment. Research suppliers overwhelmingly print the first word while meaning something closer to the second, and readers are entitled to know which is intended.1
A lyophilisation cycle has three stages and the differences between them explain most of what can go wrong. Freezing solidifies the solution, converting bulk water into ice crystals and concentrating everything else into an interstitial amorphous phase. Primary drying holds the product below the temperature at which that amorphous phase would soften, reduces the chamber pressure, and sublimes the ice directly to vapour. Secondary drying raises the shelf temperature to desorb water that remains bound to the solid matrix.
The rate-limiting stage is primary drying, and it is the stage under commercial pressure, because sublimation is slow and freeze-dryer time is expensive. Raising the shelf temperature accelerates it and risks carrying the product above its collapse temperature; shortening it leaves ice in the cake, which then melts during secondary drying and produces a partially collapsed plug with elevated moisture.
Secondary drying is the stage most often truncated, and truncation is invisible in the finished appearance. A cake can look entirely correct and carry three or four per cent residual water because the final desorption step was cut by six hours. The only way to detect it is to measure the water, which is why residual moisture is a release test in regulated manufacture and why its absence from a certificate is a substantive omission rather than a formatting one.2
Isoaspartate has the same mass as the parent. A laboratory confirming identity by molecular ion alone will report a degraded preparation as the intended compound.
On deamidationAn amorphous solid does not melt at a defined temperature; it softens over a range, and the midpoint of that range is the glass transition. For a frozen solution the relevant quantity is the glass transition of the maximally freeze-concentrated phase, and for the dried cake it is the glass transition of the residual solid. Both matter, at different stages, and both depend on composition and on water content.
During primary drying the product temperature must stay below the collapse temperature, which sits a little above the glass transition of the freeze-concentrated phase. Above it the amorphous matrix has enough mobility to flow, the pore structure that permits vapour escape closes, and the cake collapses. Sucrose-containing formulations have a glass transition of the freeze-concentrated phase in the region of minus thirty-two degrees, which imposes a genuinely cold and therefore slow primary drying stage. Mannitol behaves differently because it crystallises, giving a mechanically robust cake at the cost of losing the protective amorphous phase.
Water is a plasticiser: adding it lowers the glass transition of the dried solid substantially. This is the mechanism connecting residual moisture to storage stability. A cake with high residual water has a lower glass transition, and if storage temperature approaches it the matrix acquires mobility and every degradation pathway speeds up. A vial stored above its own glass transition is, chemically, a slow solution.
| Intended storage | Long-term condition | Intermediate | Accelerated |
|---|---|---|---|
| Room temperature | 25 °C / 60% RH, ≥12 months | 30 °C / 65% RH | 40 °C / 75% RH, 6 months |
| Room temperature, hot climatic zone | 30 °C / 65% RH, ≥12 months | not applicable | 40 °C / 75% RH, 6 months |
| Refrigerated | 5 °C ± 3 °C, ≥12 months | not applicable | 25 °C / 60% RH, 6 months |
| Frozen | −20 °C ± 5 °C, ≥12 months | not applicable | single-batch excursion study |
| Below −20 °C | case by case | not applicable | single-batch excursion study |
| Summarised from the harmonised guideline on stability testing of new drug substances and products. Frozen-storage products are not accelerated in the usual sense; the guidance substitutes a study of the effect of a short excursion above the intended condition, which is precisely the data a shipped research vial would need and does not have. | |||
Two methods dominate. Karl Fischer titration determines water specifically, by a stoichiometric reaction with iodine, and is the reference method; the coulometric variant works on the small sample masses a single vial provides. Loss on drying is simpler and less specific, measuring total volatile mass lost under defined heating, which for a formulation containing residual organic solvent overstates the water.
Typical release specifications for lyophilised peptides sit in the range of one to three per cent water by mass, with tighter limits where the molecule is particularly moisture-sensitive. The relationship to stability is not linear. Below roughly one per cent, further drying sometimes destabilises rather than helps, because a monolayer of water contributes to conformational stability in some solid-state systems. Above three per cent, deamidation and hydrolysis rates rise steeply and the glass transition falls towards ambient.
None of the twenty companies the Journal tracks reports residual moisture as a standard release test. Two will provide a figure on request. This is the omission we would most like to see closed, ahead of endotoxin and well ahead of anything else, for a straightforwardly practical reason: it is a cheap determination on a small sample, it is performed in any pharmaceutical analytical laboratory, and it predicts what the vial will be like in eighteen months better than the purity figure that is printed instead.
The alarmed version of this story would end with the excursions and leave the reader frightened. The evidence does not support that ending, and the Journal would rather publish the awkward finding than the satisfying one. A lyophilised peptide at low residual moisture, stored below its glass transition, has very little molecular mobility available for degradation. Short warm excursions in that state cost comparatively little, and the published solid-state stability literature is consistent on the point: dried peptides tolerate transient thermal insult far better than solutions do.
Two caveats keep this from being a licence. First, the protection depends on the cake being genuinely dry, which is the unmeasured variable this article keeps returning to. A cake at four per cent moisture has a much lower glass transition and much less margin. Second, repeated cycling is worse than a single excursion, particularly where a warm interval permits moisture redistribution within the cake or condensation inside the container on cooling.
The reordered risk list, on our reading, puts the reconstituted vial first, the cake with unknown residual moisture second, the multi-week domestic storage of an opened vial third, and the four hours at thirty-eight degrees in a courier van somewhere well below all of them. That ordering is not what the anxiety in this market reflects, and we think it is the more defensible one.3
The chemistry, at least, is not in dispute. Deamidation, oxidation, aggregation and hydrolysis are as well characterised as anything in pharmaceutical science, they are predictable from a sequence, and they proceed at rates set by water, temperature and time. What this trade lacks is not the science but the four or five numbers that would connect it to the vial on the shelf.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
You say no company reports residual moisture. I obtained a figure from a supplier last year without difficulty, on request, so the data exists in at least some cases. The problem may be less that it is not measured than that it is not printed.
— P. Ekundayo, Akure
I have shipped temperature-sensitive material commercially for eleven years and your coolant arithmetic is right but generous. You assume the pack starts fully frozen. In practice packs are pulled from a freezer that is opened forty times a day, and a pack that starts at minus four with a soft core has lost a fair share of its budget before the box is closed.
— J. Wenninger, Graz
A good point and one we had not considered properly. The latent heat calculation assumes a fully solid pack at its melting point, and a partially thawed pack is exactly as much worse as the missing solid fraction. We have added a sentence and would welcome any data you can share on pack condition at packing.
Your table of degradation pathways lists racemisation and then says it is essentially never reported. If it is never reported, on what basis do you list it as a real risk rather than a theoretical one?
— A. Fournier, Nantes
On the basis of the synthesis and analytical literature, where epimer formation during solid-phase assembly and during storage at extremes of pH is well characterised. What is missing is not evidence that it occurs but evidence about how much of it is present in any particular commercial vial, which is a different absence and the one we should have named.
The mean kinetic temperature explanation is the clearest I have read anywhere, including in the training my employer paid for. I have printed the sidebar and put it on the wall of the dispatch room.
— L. Fontaine, Brussels
On amber glass: it is not merely cheap, it is standard in the wider chemical supply trade for anything with a chromophore. The fact that this market ships peptides in clear glass is a sign of who is doing the filling more than of any decision about photostability.
— F. Duquesne, Lyon
The route did not close because of a rule about peptides.
We asked twenty companies three questions about stability data and print every answer, refusal and non-response.
Every degradation pathway accelerates by orders of magnitude on reconstitution, because the solvent that lyophilisation removed is the reagent most of them need.
Somebody has to be answerable for a release document. On most certificates in this market, nobody is named at all.
The arithmetic of the reference change value, worked for the analytes that matter here.
What the renal and hepatic outcome programmes actually measured, and over what duration.